Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07369895 · RECRUITING
Trial details
- NCT number
- NCT07369895
- Sponsor
- O&D BioTech Group CO., Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-28
- Primary completion
- 2028-03-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.